NK immunotherapy

natural killer cell-based immunotherapy

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for NK immunotherapy, covering 2019-09-12 to 2020-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors [Phase 1, Phase 2]